BSD Medical Corporation (NASDAQ:BSDM) (Company or BSD) (www.bsdmedical.com), a leading provider of medical systems that utilize heat therapy to treat cancer, today announced the sale and shipment of the MicroThermX Microwave System to Med-Italia Biomedica (Med-Italia), one of the largest interventional radiology/oncology distributors in Italy. This is the first European sale of BSD's MicroThermX Microwave System. BSD personnel will be attending the premiere European clinical use of the system, which will involve the treatment of a patient with a large hepatic tumor. The treatment will be carried out by a key physician in Torino, Italy. Med-Italia (http://www.meditalia.net) is a major distributor and manufacturer of products designed for the interventional radiology and oncology market in Italy. They are an exclusive distributor in Italy for a number of large medical companies, selling strategically adjacent products to the same clinicians and market that will be targeted for the MicroThermX System.
BSD is in the final process of establishing both domestic and international distribution networks dedicated to selling its new microwave ablation product line. BSD has elected to pursue the strategy of utilizing a network of leading specialty distribution firms who are focused on selling products in the field of interventional radiology, the target market for the Company's ablation product line. To support the global distribution network for the MicroThermX product line, the Company is increasing its marketing and sales staff. Additional marketing and sales resources will provide effective hands-on field training and management of the distribution network and the large number of sales personnel that this new distribution network will bring to BSD Medical.
New dye offers breakthrough in deep tissue imaging and cancer therapy